A refined symptom-based approach to diagnose pulmonary tuberculosis in children
Tuberculosis control programs place an almost exclusive emphasis on adults with sputum smear-positive tuberculosis, because they are most infectious. However, children contribute a significant proportion of the global tuberculosis caseload and experience considerable tuberculosis-related morbidity a...
Uloženo v:
| Vydáno v: | Pediatrics (Evanston) Ročník 118; číslo 5; s. e1350 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.11.2006
|
| Témata: | |
| ISSN: | 1098-4275, 1098-4275 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Tuberculosis control programs place an almost exclusive emphasis on adults with sputum smear-positive tuberculosis, because they are most infectious. However, children contribute a significant proportion of the global tuberculosis caseload and experience considerable tuberculosis-related morbidity and mortality, but few children in endemic areas have access to antituberculosis treatment. The diagnostic difficulty experienced in endemic areas with limited resources has been identified as a major factor contributing to poor treatment access. In general, there is a sense of scepticism regarding the potential value of symptom-based diagnostic approaches, because current clinical diagnostic approaches are often poorly validated. The natural history of childhood tuberculosis demonstrates that symptoms may offer good diagnostic value if they are well defined and if appropriate risk stratification is applied. This study aimed to determine the value of well-defined symptoms to diagnose childhood pulmonary tuberculosis in a tuberculosis-endemic area.
A prospective, community-based study was conducted in Cape Town, South Africa. Specific well-defined symptoms were documented in all children < 13 years of age reporting a persistent, nonremitting cough of > 2 weeks' duration; study participants were thoroughly evaluated for tuberculosis. In addition, all of the children who received antituberculosis treatment during the study period were reviewed by the investigator, irrespective of study inclusion. This concurrent disease surveillance provided a comprehensive overview of all of the childhood tuberculosis cases, allowing accurate assessment of the possible disadvantages associated with this symptom-based diagnostic approach. In the absence of an acceptable gold standard test, optimal case definition is an important consideration. Children were categorized as "bacteriologically confirmed tuberculosis," "radiologically certain tuberculosis," "probable tuberculosis," or "not tuberculosis." Bacteriologically confirmed tuberculosis was defined as the presence of acid-fast bacilli on sputum microscopy and/or Mycobacterium tuberculosis cultured from a respiratory specimen. Radiologically certain tuberculosis was defined as agreement between both independent experts that the chest radiograph indicated certain tuberculosis in the absence of bacteriologic confirmation. Probable tuberculosis was defined as the presence of suggestive radiologic signs and good clinical response to antituberculosis treatment in the absence of bacteriologic confirmation or radiologic certainty. Good clinical response was defined as complete symptom resolution and weight gain of > or = 10% of body weight at diagnosis, within 3 months of starting antituberculosis treatment. Not tuberculosis was defined as spontaneous symptom resolution or no response to antituberculosis therapy in the absence of bacteriologic confirmation or radiologic signs suggestive of tuberculosis. Pulmonary tuberculosis was defined as a symptomatic child with: (1) bacteriologically confirmed tuberculosis, (2) radiologically confirmed tuberculosis, or (3) probable tuberculosis (as defined), excluding isolated pleural effusion.
In total, 1024 children were referred for evaluation. Resolving symptoms were reported in 596 children (58.2%); 428 (41.8%) children with persistent, nonremitting symptoms at evaluation were investigated for tuberculosis. Pulmonary tuberculosis was diagnosed in 197 children; 96 were categorized as bacteriologically confirmed tuberculosis, 75 as radiologically certain tuberculosis, and 26 as probable tuberculosis. Combining a persistent nonremitting cough of > 2 weeks' duration, documented failure to thrive (in the preceding 3 months), and fatigue provided reasonable diagnostic accuracy in HIV-uninfected children (sensitivity: 62.6%; specificity: 89.8%; positive predictive value: 83.6%); the performance was better in the low-risk group (> or = 3 years; sensitivity: 82.3%; specificity: 90.2%; positive predictive value: 82.3%) than in the high-risk group (< 3 years; sensitivity: 51.8%; specificity: 92.5%; positive predictive value: 90.1%). In children with an uncertain diagnosis at presentation, clinical follow-up was a valuable diagnostic tool that further improved diagnostic accuracy, particularly in the low-risk group. Symptom-based approaches offered little diagnostic value in HIV-infected children. Three (15%) of the 20 HIV-infected children diagnosed with pulmonary tuberculosis failed to report symptoms of sufficient duration to warrant study inclusion, whereas 25% reported persistent, nonremitting symptoms in the absence of tuberculosis. In addition, the tuberculin skin test was positive in < 20% of HIV-infected children diagnosed with pulmonary tuberculosis.
The combined presence of 3 well-defined symptoms at presentation (persistent, nonremitting cough of > 2 weeks' duration; objective weight loss [documented failure to thrive] during the preceding 3 months; and reported fatigue) provided good diagnostic accuracy in HIV-uninfected children > or = 3 years of age, with clinical follow-up providing additional value. The approach performed less well in children < 3 years. However, the presence of a persistent, nonremitting cough together with documented failure to thrive still provided a fairly accurate diagnosis (sensitivity: 68.3%; specificity: 80.1%; positive predictive value: 82.1%), illustrating the importance of regular weight monitoring in young children. Clinical follow-up also offered additional diagnostic value, but caution is required, because very young children have an increased risk of rapid disease progression. The approach performed poorly in HIV-infected children. Recent household contact with an adult index case seemed to provide more diagnostic value than a positive tuberculin skin test, but novel T-cell-based assays may offer the only real improvement in sensitivity to diagnose M. tuberculosis infection in HIV-infected children. The variable diagnostic value offered by this symptom-based diagnostic approach illustrates the importance of risk stratification, as demonstrated by the fact that 11 (91.7%) of 12 children with severe disease manifestations who failed to meet the entry criteria were < 3 years of age or HIV infected. Particular emphasis should be placed on the provision of preventive chemotherapy after documented exposure and/or infection in these high-risk children. Study limitations include the small number of HIV-infected children, but on the positive side, the large number of HIV-uninfected children permitted adequate evaluation in this important group. It is often forgotten that HIV-uninfected children constitute the majority of child tuberculosis cases, even in settings where HIV is endemic. This study demonstrates the importance of ascertaining a child's HIV status before symptom-based diagnosis is attempted. Because children were recruited at both the clinic and hospital level, some selection bias may have been introduced; however, the only significant difference between the 2 groups was the proportion of HIV-infected children. Pulmonary tuberculosis was diagnosed with different levels of certainty, but no significant differences were recorded between these groups.
Pulmonary tuberculosis can be diagnosed with a reasonable degree of accuracy in HIV-uninfected children using a simple symptom-based approach. This offers the exciting prospect of improving treatment access for children, particularly in resource-limited settings where current access to antituberculosis treatment is poor. |
|---|---|
| AbstractList | Tuberculosis control programs place an almost exclusive emphasis on adults with sputum smear-positive tuberculosis, because they are most infectious. However, children contribute a significant proportion of the global tuberculosis caseload and experience considerable tuberculosis-related morbidity and mortality, but few children in endemic areas have access to antituberculosis treatment. The diagnostic difficulty experienced in endemic areas with limited resources has been identified as a major factor contributing to poor treatment access. In general, there is a sense of scepticism regarding the potential value of symptom-based diagnostic approaches, because current clinical diagnostic approaches are often poorly validated. The natural history of childhood tuberculosis demonstrates that symptoms may offer good diagnostic value if they are well defined and if appropriate risk stratification is applied. This study aimed to determine the value of well-defined symptoms to diagnose childhood pulmonary tuberculosis in a tuberculosis-endemic area.BACKGROUNDTuberculosis control programs place an almost exclusive emphasis on adults with sputum smear-positive tuberculosis, because they are most infectious. However, children contribute a significant proportion of the global tuberculosis caseload and experience considerable tuberculosis-related morbidity and mortality, but few children in endemic areas have access to antituberculosis treatment. The diagnostic difficulty experienced in endemic areas with limited resources has been identified as a major factor contributing to poor treatment access. In general, there is a sense of scepticism regarding the potential value of symptom-based diagnostic approaches, because current clinical diagnostic approaches are often poorly validated. The natural history of childhood tuberculosis demonstrates that symptoms may offer good diagnostic value if they are well defined and if appropriate risk stratification is applied. This study aimed to determine the value of well-defined symptoms to diagnose childhood pulmonary tuberculosis in a tuberculosis-endemic area.A prospective, community-based study was conducted in Cape Town, South Africa. Specific well-defined symptoms were documented in all children < 13 years of age reporting a persistent, nonremitting cough of > 2 weeks' duration; study participants were thoroughly evaluated for tuberculosis. In addition, all of the children who received antituberculosis treatment during the study period were reviewed by the investigator, irrespective of study inclusion. This concurrent disease surveillance provided a comprehensive overview of all of the childhood tuberculosis cases, allowing accurate assessment of the possible disadvantages associated with this symptom-based diagnostic approach. In the absence of an acceptable gold standard test, optimal case definition is an important consideration. Children were categorized as "bacteriologically confirmed tuberculosis," "radiologically certain tuberculosis," "probable tuberculosis," or "not tuberculosis." Bacteriologically confirmed tuberculosis was defined as the presence of acid-fast bacilli on sputum microscopy and/or Mycobacterium tuberculosis cultured from a respiratory specimen. Radiologically certain tuberculosis was defined as agreement between both independent experts that the chest radiograph indicated certain tuberculosis in the absence of bacteriologic confirmation. Probable tuberculosis was defined as the presence of suggestive radiologic signs and good clinical response to antituberculosis treatment in the absence of bacteriologic confirmation or radiologic certainty. Good clinical response was defined as complete symptom resolution and weight gain of > or = 10% of body weight at diagnosis, within 3 months of starting antituberculosis treatment. Not tuberculosis was defined as spontaneous symptom resolution or no response to antituberculosis therapy in the absence of bacteriologic confirmation or radiologic signs suggestive of tuberculosis. Pulmonary tuberculosis was defined as a symptomatic child with: (1) bacteriologically confirmed tuberculosis, (2) radiologically confirmed tuberculosis, or (3) probable tuberculosis (as defined), excluding isolated pleural effusion.METHODSA prospective, community-based study was conducted in Cape Town, South Africa. Specific well-defined symptoms were documented in all children < 13 years of age reporting a persistent, nonremitting cough of > 2 weeks' duration; study participants were thoroughly evaluated for tuberculosis. In addition, all of the children who received antituberculosis treatment during the study period were reviewed by the investigator, irrespective of study inclusion. This concurrent disease surveillance provided a comprehensive overview of all of the childhood tuberculosis cases, allowing accurate assessment of the possible disadvantages associated with this symptom-based diagnostic approach. In the absence of an acceptable gold standard test, optimal case definition is an important consideration. Children were categorized as "bacteriologically confirmed tuberculosis," "radiologically certain tuberculosis," "probable tuberculosis," or "not tuberculosis." Bacteriologically confirmed tuberculosis was defined as the presence of acid-fast bacilli on sputum microscopy and/or Mycobacterium tuberculosis cultured from a respiratory specimen. Radiologically certain tuberculosis was defined as agreement between both independent experts that the chest radiograph indicated certain tuberculosis in the absence of bacteriologic confirmation. Probable tuberculosis was defined as the presence of suggestive radiologic signs and good clinical response to antituberculosis treatment in the absence of bacteriologic confirmation or radiologic certainty. Good clinical response was defined as complete symptom resolution and weight gain of > or = 10% of body weight at diagnosis, within 3 months of starting antituberculosis treatment. Not tuberculosis was defined as spontaneous symptom resolution or no response to antituberculosis therapy in the absence of bacteriologic confirmation or radiologic signs suggestive of tuberculosis. Pulmonary tuberculosis was defined as a symptomatic child with: (1) bacteriologically confirmed tuberculosis, (2) radiologically confirmed tuberculosis, or (3) probable tuberculosis (as defined), excluding isolated pleural effusion.In total, 1024 children were referred for evaluation. Resolving symptoms were reported in 596 children (58.2%); 428 (41.8%) children with persistent, nonremitting symptoms at evaluation were investigated for tuberculosis. Pulmonary tuberculosis was diagnosed in 197 children; 96 were categorized as bacteriologically confirmed tuberculosis, 75 as radiologically certain tuberculosis, and 26 as probable tuberculosis. Combining a persistent nonremitting cough of > 2 weeks' duration, documented failure to thrive (in the preceding 3 months), and fatigue provided reasonable diagnostic accuracy in HIV-uninfected children (sensitivity: 62.6%; specificity: 89.8%; positive predictive value: 83.6%); the performance was better in the low-risk group (> or = 3 years; sensitivity: 82.3%; specificity: 90.2%; positive predictive value: 82.3%) than in the high-risk group (< 3 years; sensitivity: 51.8%; specificity: 92.5%; positive predictive value: 90.1%). In children with an uncertain diagnosis at presentation, clinical follow-up was a valuable diagnostic tool that further improved diagnostic accuracy, particularly in the low-risk group. Symptom-based approaches offered little diagnostic value in HIV-infected children. Three (15%) of the 20 HIV-infected children diagnosed with pulmonary tuberculosis failed to report symptoms of sufficient duration to warrant study inclusion, whereas 25% reported persistent, nonremitting symptoms in the absence of tuberculosis. In addition, the tuberculin skin test was positive in < 20% of HIV-infected children diagnosed with pulmonary tuberculosis.RESULTSIn total, 1024 children were referred for evaluation. Resolving symptoms were reported in 596 children (58.2%); 428 (41.8%) children with persistent, nonremitting symptoms at evaluation were investigated for tuberculosis. Pulmonary tuberculosis was diagnosed in 197 children; 96 were categorized as bacteriologically confirmed tuberculosis, 75 as radiologically certain tuberculosis, and 26 as probable tuberculosis. Combining a persistent nonremitting cough of > 2 weeks' duration, documented failure to thrive (in the preceding 3 months), and fatigue provided reasonable diagnostic accuracy in HIV-uninfected children (sensitivity: 62.6%; specificity: 89.8%; positive predictive value: 83.6%); the performance was better in the low-risk group (> or = 3 years; sensitivity: 82.3%; specificity: 90.2%; positive predictive value: 82.3%) than in the high-risk group (< 3 years; sensitivity: 51.8%; specificity: 92.5%; positive predictive value: 90.1%). In children with an uncertain diagnosis at presentation, clinical follow-up was a valuable diagnostic tool that further improved diagnostic accuracy, particularly in the low-risk group. Symptom-based approaches offered little diagnostic value in HIV-infected children. Three (15%) of the 20 HIV-infected children diagnosed with pulmonary tuberculosis failed to report symptoms of sufficient duration to warrant study inclusion, whereas 25% reported persistent, nonremitting symptoms in the absence of tuberculosis. In addition, the tuberculin skin test was positive in < 20% of HIV-infected children diagnosed with pulmonary tuberculosis.The combined presence of 3 well-defined symptoms at presentation (persistent, nonremitting cough of > 2 weeks' duration; objective weight loss [documented failure to thrive] during the preceding 3 months; and reported fatigue) provided good diagnostic accuracy in HIV-uninfected children > or = 3 years of age, with clinical follow-up providing additional value. The approach perfor Tuberculosis control programs place an almost exclusive emphasis on adults with sputum smear-positive tuberculosis, because they are most infectious. However, children contribute a significant proportion of the global tuberculosis caseload and experience considerable tuberculosis-related morbidity and mortality, but few children in endemic areas have access to antituberculosis treatment. The diagnostic difficulty experienced in endemic areas with limited resources has been identified as a major factor contributing to poor treatment access. In general, there is a sense of scepticism regarding the potential value of symptom-based diagnostic approaches, because current clinical diagnostic approaches are often poorly validated. The natural history of childhood tuberculosis demonstrates that symptoms may offer good diagnostic value if they are well defined and if appropriate risk stratification is applied. This study aimed to determine the value of well-defined symptoms to diagnose childhood pulmonary tuberculosis in a tuberculosis-endemic area. A prospective, community-based study was conducted in Cape Town, South Africa. Specific well-defined symptoms were documented in all children < 13 years of age reporting a persistent, nonremitting cough of > 2 weeks' duration; study participants were thoroughly evaluated for tuberculosis. In addition, all of the children who received antituberculosis treatment during the study period were reviewed by the investigator, irrespective of study inclusion. This concurrent disease surveillance provided a comprehensive overview of all of the childhood tuberculosis cases, allowing accurate assessment of the possible disadvantages associated with this symptom-based diagnostic approach. In the absence of an acceptable gold standard test, optimal case definition is an important consideration. Children were categorized as "bacteriologically confirmed tuberculosis," "radiologically certain tuberculosis," "probable tuberculosis," or "not tuberculosis." Bacteriologically confirmed tuberculosis was defined as the presence of acid-fast bacilli on sputum microscopy and/or Mycobacterium tuberculosis cultured from a respiratory specimen. Radiologically certain tuberculosis was defined as agreement between both independent experts that the chest radiograph indicated certain tuberculosis in the absence of bacteriologic confirmation. Probable tuberculosis was defined as the presence of suggestive radiologic signs and good clinical response to antituberculosis treatment in the absence of bacteriologic confirmation or radiologic certainty. Good clinical response was defined as complete symptom resolution and weight gain of > or = 10% of body weight at diagnosis, within 3 months of starting antituberculosis treatment. Not tuberculosis was defined as spontaneous symptom resolution or no response to antituberculosis therapy in the absence of bacteriologic confirmation or radiologic signs suggestive of tuberculosis. Pulmonary tuberculosis was defined as a symptomatic child with: (1) bacteriologically confirmed tuberculosis, (2) radiologically confirmed tuberculosis, or (3) probable tuberculosis (as defined), excluding isolated pleural effusion. In total, 1024 children were referred for evaluation. Resolving symptoms were reported in 596 children (58.2%); 428 (41.8%) children with persistent, nonremitting symptoms at evaluation were investigated for tuberculosis. Pulmonary tuberculosis was diagnosed in 197 children; 96 were categorized as bacteriologically confirmed tuberculosis, 75 as radiologically certain tuberculosis, and 26 as probable tuberculosis. Combining a persistent nonremitting cough of > 2 weeks' duration, documented failure to thrive (in the preceding 3 months), and fatigue provided reasonable diagnostic accuracy in HIV-uninfected children (sensitivity: 62.6%; specificity: 89.8%; positive predictive value: 83.6%); the performance was better in the low-risk group (> or = 3 years; sensitivity: 82.3%; specificity: 90.2%; positive predictive value: 82.3%) than in the high-risk group (< 3 years; sensitivity: 51.8%; specificity: 92.5%; positive predictive value: 90.1%). In children with an uncertain diagnosis at presentation, clinical follow-up was a valuable diagnostic tool that further improved diagnostic accuracy, particularly in the low-risk group. Symptom-based approaches offered little diagnostic value in HIV-infected children. Three (15%) of the 20 HIV-infected children diagnosed with pulmonary tuberculosis failed to report symptoms of sufficient duration to warrant study inclusion, whereas 25% reported persistent, nonremitting symptoms in the absence of tuberculosis. In addition, the tuberculin skin test was positive in < 20% of HIV-infected children diagnosed with pulmonary tuberculosis. The combined presence of 3 well-defined symptoms at presentation (persistent, nonremitting cough of > 2 weeks' duration; objective weight loss [documented failure to thrive] during the preceding 3 months; and reported fatigue) provided good diagnostic accuracy in HIV-uninfected children > or = 3 years of age, with clinical follow-up providing additional value. The approach performed less well in children < 3 years. However, the presence of a persistent, nonremitting cough together with documented failure to thrive still provided a fairly accurate diagnosis (sensitivity: 68.3%; specificity: 80.1%; positive predictive value: 82.1%), illustrating the importance of regular weight monitoring in young children. Clinical follow-up also offered additional diagnostic value, but caution is required, because very young children have an increased risk of rapid disease progression. The approach performed poorly in HIV-infected children. Recent household contact with an adult index case seemed to provide more diagnostic value than a positive tuberculin skin test, but novel T-cell-based assays may offer the only real improvement in sensitivity to diagnose M. tuberculosis infection in HIV-infected children. The variable diagnostic value offered by this symptom-based diagnostic approach illustrates the importance of risk stratification, as demonstrated by the fact that 11 (91.7%) of 12 children with severe disease manifestations who failed to meet the entry criteria were < 3 years of age or HIV infected. Particular emphasis should be placed on the provision of preventive chemotherapy after documented exposure and/or infection in these high-risk children. Study limitations include the small number of HIV-infected children, but on the positive side, the large number of HIV-uninfected children permitted adequate evaluation in this important group. It is often forgotten that HIV-uninfected children constitute the majority of child tuberculosis cases, even in settings where HIV is endemic. This study demonstrates the importance of ascertaining a child's HIV status before symptom-based diagnosis is attempted. Because children were recruited at both the clinic and hospital level, some selection bias may have been introduced; however, the only significant difference between the 2 groups was the proportion of HIV-infected children. Pulmonary tuberculosis was diagnosed with different levels of certainty, but no significant differences were recorded between these groups. Pulmonary tuberculosis can be diagnosed with a reasonable degree of accuracy in HIV-uninfected children using a simple symptom-based approach. This offers the exciting prospect of improving treatment access for children, particularly in resource-limited settings where current access to antituberculosis treatment is poor. |
| Author | Beyers, Nulda Lombard, Carl Gie, Robert P Hesseling, Anneke C Enarson, Donald A Schaaf, H Simon Marais, Ben J |
| Author_xml | – sequence: 1 givenname: Ben J surname: Marais fullname: Marais, Ben J email: bjmarais@sun.ac.za organization: Desmond Tutu Tuberculosis Centre and Department of Paediatrics and Child Health, Tygerberg Children's Hospital, Stellenbosch University, Cape Town, South Africa. bjmarais@sun.ac.za – sequence: 2 givenname: Robert P surname: Gie fullname: Gie, Robert P – sequence: 3 givenname: Anneke C surname: Hesseling fullname: Hesseling, Anneke C – sequence: 4 givenname: H Simon surname: Schaaf fullname: Schaaf, H Simon – sequence: 5 givenname: Carl surname: Lombard fullname: Lombard, Carl – sequence: 6 givenname: Donald A surname: Enarson fullname: Enarson, Donald A – sequence: 7 givenname: Nulda surname: Beyers fullname: Beyers, Nulda |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17079536$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUEtLxDAYDKK4D716lJy8dU3SvHpcFl-wsBc9lzy-upE2qU172H9vwRU8zXzDMMw3K3QZUwSE7ijZUMHZYw8-bxghsiCCVhdoSUmlC86UuPzHF2iV8xchhAvFrtGCKqIqUcolOmzxAE2I4HE-df2YusKaPF-m74dk3BGPCftgPmPKgPup7VI0wwmPk4XBTW3KIeMQsTuG1g8Qb9BVY9oMt2dco4_np_fda7E_vLzttvvClSUfC15ByYi2Cpzi3leWASguDFEloaWkUsjKa66FAGgaa8SsUG08scCEcsDW6OE3d275PUEe6y5kB21rIqQp11JTqqTms_H-bJxsB77uh9DND9R_E7AfyytgaQ |
| CitedBy_id | crossref_primary_10_1097_INF_0000000000001342 crossref_primary_10_1164_rccm_201107_1355OC crossref_primary_10_1371_journal_pgph_0004016 crossref_primary_10_1164_rccm_201406_1165OC crossref_primary_10_1093_jpids_piab113 crossref_primary_10_1179_146532808X270626 crossref_primary_10_1002_ppul_20787 crossref_primary_10_1097_MD_0000000000002045 crossref_primary_10_1186_s12879_020_05653_9 crossref_primary_10_1016_j_pedneo_2013_01_019 crossref_primary_10_1093_tropej_fmv073 crossref_primary_10_1016_j_pcl_2015_08_002 crossref_primary_10_1128_CVI_00501_12 crossref_primary_10_1183_13993003_03028_2020 crossref_primary_10_1371_journal_pntd_0010621 crossref_primary_10_1016_j_ijid_2015_12_006 crossref_primary_10_1016_j_ijid_2017_01_038 crossref_primary_10_1016_j_tips_2011_06_003 crossref_primary_10_1093_cid_cix099 crossref_primary_10_5812_pedinfect_9140 crossref_primary_10_1097_INF_0b013e31827d77b7 crossref_primary_10_1016_j_ijtb_2021_06_007 crossref_primary_10_1016_j_vaccine_2011_04_020 crossref_primary_10_1371_journal_pmed_1001105 crossref_primary_10_1128_JCM_00702_20 crossref_primary_10_1186_1471_2334_9_96 crossref_primary_10_1016_S2222_1808_15_60928_8 crossref_primary_10_1542_peds_2007_3138 crossref_primary_10_1016_j_jinf_2018_07_002 crossref_primary_10_1097_INF_0000000000001115 crossref_primary_10_1097_INF_0b013e31823eeaf9 crossref_primary_10_1007_s10096_015_2507_6 crossref_primary_10_1016_j_prrv_2007_04_002 crossref_primary_10_1093_jpids_piaf045 crossref_primary_10_1136_adc_2008_147801 crossref_primary_10_3389_fped_2019_00159 crossref_primary_10_1097_RHU_0b013e31829ce750 crossref_primary_10_3201_eid2311_170171 crossref_primary_10_3390_tropicalmed10040106 crossref_primary_10_1007_s15014_016_0658_2 crossref_primary_10_1086_518659 crossref_primary_10_1016_j_rmcr_2020_101229 crossref_primary_10_1179_2046905514Y_0000000128 crossref_primary_10_2471_BLT_09_062893 crossref_primary_10_1183_09031936_00153408 crossref_primary_10_1016_j_arcped_2009_07_021 crossref_primary_10_1016_j_anpedi_2009_12_017 crossref_primary_10_1183_09031936_00194311 crossref_primary_10_1097_INF_0b013e3181ee23ae crossref_primary_10_1111_lam_13402 crossref_primary_10_1097_INF_0b013e3181c61ddb crossref_primary_10_1371_journal_pone_0284363 crossref_primary_10_1586_eri_10_9 crossref_primary_10_3389_fpubh_2024_1374703 crossref_primary_10_1093_infdis_jir413 crossref_primary_10_1186_s12889_016_3193_8 crossref_primary_10_1016_j_arcped_2013_10_014 crossref_primary_10_1016_S2213_2600_15_00095_8 crossref_primary_10_1016_S1473_3099_20_30177_8 crossref_primary_10_1016_S2213_2600_17_30496_4 crossref_primary_10_1016_j_pulmoe_2020_01_001 crossref_primary_10_1080_20469047_2017_1319898 crossref_primary_10_1097_INF_0b013e318243e27b crossref_primary_10_1016_j_apjtm_2016_07_017 crossref_primary_10_1186_1471_2334_12_211 crossref_primary_10_1007_s00112_015_0007_5 crossref_primary_10_1111_j_1440_1843_2009_01692_x crossref_primary_10_1186_s12889_015_1883_2 crossref_primary_10_1093_tropej_fmp115 crossref_primary_10_1128_JCM_01756_20 crossref_primary_10_1136_bmjgh_2024_016416 crossref_primary_10_1007_s00431_008_0730_1 crossref_primary_10_1590_S0034_89102010005000019 crossref_primary_10_1016_j_ccm_2019_08_003 crossref_primary_10_1016_j_idc_2010_04_004 crossref_primary_10_1093_ofid_ofac548 crossref_primary_10_1183_13993003_00890_2015 crossref_primary_10_1016_j_radcr_2024_10_129 crossref_primary_10_1186_s41479_016_0023_9 crossref_primary_10_1590_s1678_9946202062081 crossref_primary_10_1136_bmjopen_2021_058388 crossref_primary_10_1186_1471_2334_14_295 crossref_primary_10_5005_jp_journals_10081_1229 crossref_primary_10_1186_s13052_022_01288_5 crossref_primary_10_1007_s10096_018_3272_0 crossref_primary_10_1016_S1473_3099_10_70164_X crossref_primary_10_1080_1040841X_2016_1262813 crossref_primary_10_1007_s12098_010_0353_1 crossref_primary_10_1371_journal_pone_0180725 crossref_primary_10_1093_infdis_jis008 crossref_primary_10_1016_j_rppnen_2017_06_004 crossref_primary_10_1542_peds_2008_0611 crossref_primary_10_1097_INF_0b013e31825cbb3b crossref_primary_10_1016_j_ijid_2017_03_009 crossref_primary_10_1111_jpc_12503 crossref_primary_10_1136_bcr_2020_237580 crossref_primary_10_1136_bmjpo_2018_000308 crossref_primary_10_1080_09540121_2013_772281 crossref_primary_10_1128_CVI_00525_13 crossref_primary_10_1002_14651858_CD016071_pub2 crossref_primary_10_1371_journal_pone_0049658 crossref_primary_10_1016_j_lanmic_2024_100963 crossref_primary_10_1128_JCM_02057_18 crossref_primary_10_1001_jamapediatrics_2020_6078 crossref_primary_10_1055_a_2230_6958 crossref_primary_10_1007_s00112_015_3377_9 crossref_primary_10_1016_j_prrv_2013_11_007 crossref_primary_10_1016_j_pcl_2008_10_004 crossref_primary_10_1016_S0163_4453_17_30195_0 crossref_primary_10_1186_s12916_021_01983_w crossref_primary_10_1007_s00247_009_1199_4 crossref_primary_10_1093_cid_ciad449 crossref_primary_10_1183_09031936_00033912 crossref_primary_10_1371_journal_pone_0153914 crossref_primary_10_1093_cid_cir772 crossref_primary_10_1371_journal_pmed_1004285 crossref_primary_10_1542_peds_2017_3918 crossref_primary_10_1007_s10405_014_0779_7 crossref_primary_10_1097_MCP_0000000000000950 crossref_primary_10_1016_j_jfma_2011_11_002 crossref_primary_10_1002_jia2_25617 crossref_primary_10_1016_j_diagmicrobio_2009_11_002 crossref_primary_10_1097_HP_0000000000001313 crossref_primary_10_1093_infdis_jir453 crossref_primary_10_1017_S0950268810001809 crossref_primary_10_1155_2012_818219 crossref_primary_10_1186_s12879_023_08708_9 crossref_primary_10_1097_QAI_0000000000000806 crossref_primary_10_1186_1471_2334_13_31 crossref_primary_10_2217_fmb_09_39 crossref_primary_10_1097_INF_0b013e31817e83f4 crossref_primary_10_1093_cid_ciab018 crossref_primary_10_1097_CPM_0b013e31827a6e28 crossref_primary_10_1097_QAI_0000000000001335 crossref_primary_10_1016_j_tube_2016_09_021 crossref_primary_10_2147_IDR_S295798 crossref_primary_10_1093_cid_ciab652 crossref_primary_10_3390_pathogens13060467 crossref_primary_10_1007_s12098_010_0307_7 crossref_primary_10_1016_j_prrv_2010_09_002 crossref_primary_10_1080_20469047_2020_1848270 crossref_primary_10_1155_2012_401896 crossref_primary_10_1056_NEJMra1008049 crossref_primary_10_1542_peds_2018_2065 crossref_primary_10_1097_INF_0000000000001774 crossref_primary_10_1093_cid_cir823 crossref_primary_10_1093_cid_ciw036 crossref_primary_10_1186_1471_2334_14_401 crossref_primary_10_1016_j_ijid_2020_06_001 crossref_primary_10_1097_INF_0b013e3182615270 crossref_primary_10_1097_MOP_0000000000000897 crossref_primary_10_1097_MOP_0000000000001226 crossref_primary_10_1016_S1473_3099_08_70182_8 crossref_primary_10_1093_infdis_jir860 crossref_primary_10_1186_s12879_020_05194_1 crossref_primary_10_1007_s12519_013_0404_6 crossref_primary_10_1186_1471_2334_14_11 crossref_primary_10_1371_journal_pone_0003901 crossref_primary_10_1016_S2213_2600_19_30137_7 crossref_primary_10_1093_cid_cis190 crossref_primary_10_1371_journal_pone_0097267 crossref_primary_10_3390_pathogens11040381 crossref_primary_10_1097_INF_0000000000000847 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1542/peds.2006-0519 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1098-4275 |
| ExternalDocumentID | 17079536 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -ET ..I .55 .GJ 0R~ 123 18M 1CY 1HT 26- 29O 2KS 2QL 2WC 36B 39C 4.4 41~ 53G 5RE 5VS 6PF 7K8 85S 8F7 8GL 96U AAAMJ AAHTB AAIKC AAJMC AAKAS AAMNW AAQOH AAWTL AAWTO AAYOK ABCZD ABIVO ABJNI ABOCM ABPEJ ABPPZ ACBMB ACGFO ACGOD ACNCT ACPRK ADCOW ADZCM AENEX AFAZI AFFNX AFHKK AFOSN AFRAH AGFXO AHMBA AJUXI ALMA_UNASSIGNED_HOLDINGS BKOMP CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD EX3 F5P F8P FEDTE GICCO GOZPB GX1 H13 HF~ HVGLF IAG IAO ICJ IEA IER IHR IMI INH INR IOF IPO IPY ISE ITC IVC KO8 KQ8 L7B LXL LXN LXY N4W N9A NEJ NPM OHT OK1 OMK OVD P0W P2P PDE PQQKQ Q.- RHI SJN TAE TEORI TR2 TWZ UBE UHB UMD W8F WH7 WHG WOQ WOW WQ9 X7M XJT XOL XZL YHG YHZ YOC YQI YQJ YZZ ZGI ZRR ZXP ~KM ~X8 7X8 ABUFD |
| ID | FETCH-LOGICAL-c334t-49e3208b7ec74dd9b2ee745a073013616569d84855eeffba516518ad0be257ce2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 219 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000241731700087&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1098-4275 |
| IngestDate | Tue Oct 21 14:05:39 EDT 2025 Fri Jun 06 19:39:50 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c334t-49e3208b7ec74dd9b2ee745a073013616569d84855eeffba516518ad0be257ce2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 17079536 |
| PQID | 68117684 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_68117684 pubmed_primary_17079536 |
| PublicationCentury | 2000 |
| PublicationDate | 2006-Nov 20061101 |
| PublicationDateYYYYMMDD | 2006-11-01 |
| PublicationDate_xml | – month: 11 year: 2006 text: 2006-Nov |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Pediatrics (Evanston) |
| PublicationTitleAlternate | Pediatrics |
| PublicationYear | 2006 |
| SSID | ssj0004572 |
| Score | 2.3495154 |
| Snippet | Tuberculosis control programs place an almost exclusive emphasis on adults with sputum smear-positive tuberculosis, because they are most infectious. However,... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | e1350 |
| SubjectTerms | Adolescent Child Child, Preschool Female Humans Infant Male Prospective Studies Tuberculosis, Pulmonary - diagnosis |
| Title | A refined symptom-based approach to diagnose pulmonary tuberculosis in children |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/17079536 https://www.proquest.com/docview/68117684 |
| Volume | 118 |
| WOSCitedRecordID | wos000241731700087&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA7Vinjx_ajPHLyGtptskgVBilg82NqDSm8lm0ygUHfX7lbovzfZB3gRD16WsLBhmZ2Z72Mn8w1Ct1x6FLOacKoMYbGiRFrGiHH4IGId9Uw5reH9WYzHcjqNJi101_TC-GOVTU4sE7VJtf9H3uW-I5JLdp99Ej8zytdW6wEaG6hNHZHxPi2mP7XCRVXrjCRhgQhrycaQBd0MTCXVTTyD-Z1cliAz3Pvf6-2j3Zpc4kHlDQeoBckh2h7V5fMj9DLADhDd0uB8_ZEVLj96FDO4URbHRYpNdfgOcLZauH3Vco2LVQxLvVqk-TzH8wQ3HeDH6G34-PrwROqJCkRTygrCIqBBT8YCtGDGRHEAIFioyjin3CvxREZ6vRgAa2MVujt9qUwvBhfaGoITtJmkCZwhbKIeBya11MoyyePIMQ9qQwtWcGVD1kE3jaFmzmN9GUIlkK7yWWOqDjqtbD3LKmGNWd_L9YWUn__57AXaKT9f2RR4idrWxSpcoS39Vczz5XXpCO46noy-ActivnE |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+refined+symptom-based+approach+to+diagnose+pulmonary+tuberculosis+in+children&rft.jtitle=Pediatrics+%28Evanston%29&rft.au=Marais%2C+Ben+J&rft.au=Gie%2C+Robert+P&rft.au=Hesseling%2C+Anneke+C&rft.au=Schaaf%2C+H+Simon&rft.date=2006-11-01&rft.issn=1098-4275&rft.eissn=1098-4275&rft.volume=118&rft.issue=5&rft.spage=e1350&rft_id=info:doi/10.1542%2Fpeds.2006-0519&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-4275&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-4275&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-4275&client=summon |